NASDAQ
BioLineRx Ltd. (BLRX) has a free cash flow growth of -54.52% as of Friday, May 29, 2026. This represents a 76.15% increase compared to its 12-month average of -228.59%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.